QA: Seelos Therapeutics INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2017_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 3,634,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,006,000
3 remainder_Assets 60,000
4 LiabilitiesCurrent 11,294,000
5 LiabilitiesNoncurrent 76,000
6 remainder_Liabilities 846,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,575,998
9 ResearchAndDevelopmentExpense 8,037,933
10 remainder_Expenses 3,591,316
11 remainder_Revenues 5,388,131
12 remainder_NetIncome 4,932,129
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,700,000
1 Liabilities 12,216,000
2 Expenses 19,205,247
3 Revenues 5,388,131
4 StockholdersEquity -7,516,000
5 NetIncome -8,884,987
6 ComprehensiveNetIncome -8,884,987
7 BaseVar 23,220,754
8 EconomicCapitalRatiobeforeLimitedLiability -2.99
9 EconomicCapitalRatio 0.691

Edgar->Model Mapping

Feature Distribution

Change over Time